Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release on Audited Financial Results for the quarter and year March 31, 2026.
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF reported strong Q4FY26 results with revenue of Rs 30.35 crore, up 13% YoY; EBITDA of Rs 12.17 crore, up 40% YoY with margin at 40.1%; and PAT of Rs 8.36 crore, up 29% YoY with margin at 27.5%. For the full year FY26, revenue grew 48% to Rs 104.35 crore, EBITDA rose 32% to Rs 37.70 crore and PAT increased 28% to Rs 24.48 crore. The company operates 7 hubs and 28 spokes and achieved a 58% clinical pregnancy success rate on first IVF attempt. It also became India's first IVF chain to integrate AI-led embryology (SiD and ERICA platforms) via a partnership with UK-based IVF 2.0. Expansion plans include 19 new IVF hubs funded by IPO proceeds, with 3 hubs expected operational soon, scaling to 10 hubs in FY27.
Strong double-digit growth across all metrics with margin expansion signals improving operational leverage and business scalability. The 48% full-year revenue growth and 40%+ EBITDA margin in Q4 are particularly positive. AI integration and hub expansion plans provide medium-term growth visibility.